Osteopenia Completed Phase 4 Trials for Alendronic acid (DB00630)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00006180Bone Loss in Premenopausal Women With DepressionTreatment
NCT00504166Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal WomenPrevention